Major progress has been achieved in autosomal dominant polycystic kidney di
sease in the last 30 years; Progress in imaging procedures has been decisiv
e for diagnosis (by ultasonography), management of kidney and liver complic
ations (by CT scan), and investigation and sometimes management of intracra
nial aneurysms (by MRI-angiography and endovascular treatment procedures).
On the other hand, progress in molecular genetics has led to the identifica
tion of PKD1 and PDK2 genes, and their respective gene products, polycystin
1 and 2. A two-hit model for cyst formation has recently been put forward.
The link between the gene defects and cyst fluid formation and progression
is still unknown. In addition, cystic and non-cystic lesions coexist in th
e disease, underlining that the primary molecular defect is located upstrea
m of the mechanism of cyst formation.